Atomwise uses deep neural networks to help discover new medicines. Our customers are top researchers at institutions such as Merck and the Dana Farber Cancer Institute (see http://www.atomwise.com/clients/). We're backed by science-heavy VCs, including Data Collective, Khosla Ventures, and DFJ. Our work tackles some of the biggest problems of our time: cancer, multiple sclerosis, malaria, ebola, and antibiotics for drug-resistant bugs. We’ve already shown that modern machine learning can set a new bar for predictive accuracy in structure-based drug design, and we want your help in pushing that accuracy even further.
We’re looking both for people with machine learning expertise, and for people with computational biology/chemistry expertise. If you’ve got both, all the better! Please see our full job descriptions here: http://www.atomwise.com/careers/